{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:53:25Z","timestamp":1792076005335,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR23111\/MED\/30\/1852\/2017"],"award-info":[{"award-number":["BT\/PR23111\/MED\/30\/1852\/2017"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR23111\/MED\/30\/1852\/2017"],"award-info":[{"award-number":["BT\/PR23111\/MED\/30\/1852\/2017"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background and objectives<\/jats:title>\n                <jats:p>Data on the association of vitamin D levels and clinical phenotype and disease activity in systemic lupus erythematosus (SLE) is controversial. Further, the optimal dose of oral vitamin D supplementation in SLE is not clear. Thus, the present study was designed to determine the association of plasma vitamin D levels with clinical phenotype, disease variables and serology in a large, cohort of SLE from South Asia and to evaluate the short-term effect of two different dosage regimens of oral vitamin D supplementation on disease flares and plasma vitamin D levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a two-phase study. Phase I was a cross-sectional analytical study of patients from north (26.85\u00b0 N) and south India (11.94\u00b0 N). Plasma 25-hydroxyvitamin-D(25(OH)D) was measured, and its association with demography, serology, disease activity, Galectin-9 and CXCL-10 was analysed. In phase II, patients with SLEDAI-2KG\u2009&lt;\u200910 and on stable immunosuppression were randomised to receive either high dose (weekly 60,000\u00a0U*5, followed by 60,000\u00a0U monthly) or routine dose (30,000 U monthly) oral vitamin D. Outcomes were assessed at 6 months<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Phase I included 702 patients with a mean age of 29.46 + 10.7 years. The median plasma vitamin D was 22.83 (13.8\u201331.8) ng\/ml. Deficiency (&lt;\u200920 ng\/ml) was seen in 41.5% of patients. Patients from South India had higher vitamin D levels (27.06 \u00b1 20.21 ng\/dl) as compared to North India (17.15 \u00b1 16.07 ng\/ml) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). Univariate analyses demonstrated weak negative correlation of vitamin D with SLEDAI2K and positive correlation with age. Galactin-9 had modest correlation with SLEDAI2K but not with vitamin D levels. On multiple linear regression, centre of recruitment (<jats:italic>\u03b2<\/jats:italic>\u2009=\u20094.37) and age (<jats:italic>\u03b2<\/jats:italic> = 0.18) predicted (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.05) plasma vitamin D levels.<\/jats:p>\n                <jats:p>In the phase II, 91 randomised to 2 groups completed 6 months. Median change in plasma vitamin D levels was more in high dose (9.5 versus 2.6 ng\/ml; <jats:italic>p<\/jats:italic>\u00a0=\u20090.04). There were 14 SLE flares and six minor adverse events which were equal across both groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Vitamin D deficiency is common in SLE. Geographical location of residence is the major determinant rather than the disease activity. The IFN regulated proteins reflect disease activity independent of vitamin D levels. High-dose oral vitamin D supplementation seems safe and more effective in improving vitamin D levels in SLE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The second phase of this study was a registered randomised controlled trial CTRI\/2019\/06\/019658 [registered on: 14\/06\/2019].<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-022-02976-7","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T06:03:03Z","timestamp":1672725783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical and serological association of plasma 25-hydroxyvitamin D (25(OH)D) levels in lupus and the short-term effects of oral vitamin D supplementation"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3643-3989","authenticated-orcid":false,"given":"Chengappa","family":"Kavadichanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratibha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya","family":"Maurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Tota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aberaame","family":"Kiroubagarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8123-7514","authenticated-orcid":false,"given":"Deepika","family":"Kounassegarane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4049-401X","authenticated-orcid":false,"given":"Swathi","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1518-6031","authenticated-orcid":false,"given":"Vir Singh","family":"Negi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2187-5186","authenticated-orcid":false,"given":"Amita","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"issue":"5","key":"2976_CR1","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1600-0781.2008.00373.x","volume":"24","author":"C Cusack","year":"2008","unstructured":"Cusack C, Danby C, Fallon JC, Ho WL, Murray B, Brady J, et al. Photoprotective behaviour and sunscreen use: impact on vitamin D levels in cutaneous lupus erythematosus. Photodermatol Photoimmunol Photomed. 2008;24(5):260\u20137.","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"7","key":"2976_CR2","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/jclinpath-2012-201301","volume":"66","author":"JL Waldron","year":"2013","unstructured":"Waldron JL, Ashby HL, Cornes MP, Bechervaise J, Razavi C, Thomas OL, et al. Vitamin D: a negative acute phase reactant. J Clin Pathol. 2013;66(7):620\u20132.","journal-title":"J Clin Pathol"},{"issue":"4","key":"2976_CR3","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.coph.2010.04.001","volume":"10","author":"F Baeke","year":"2010","unstructured":"Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010;10(4):482\u201396.","journal-title":"Curr Opin Pharmacol"},{"issue":"3","key":"2976_CR4","first-page":"1634","volume":"179","author":"S Chen","year":"2007","unstructured":"Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol Baltim Md 1950. 2007;179(3):1634\u201347.","journal-title":"J Immunol Baltim Md 1950"},{"issue":"1","key":"2976_CR5","first-page":"1","volume":"9","author":"T Hassanalilou","year":"2017","unstructured":"Hassanalilou T, Khalili L, Ghavamzadeh S, Shokri A, Payahoo L, Bishak YK. Role of vitamin D deficiency in systemic lupus erythematosus incidence and aggravation. Auto-Immun Highlights. 2017;9(1):1.","journal-title":"Auto-Immun Highlights"},{"issue":"1","key":"2976_CR6","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1186\/ar4479","volume":"16","author":"M Mandal","year":"2014","unstructured":"Mandal M, Tripathy R, Panda AK, Pattanaik SS, Dakua S, Pradhan AK, et al. Vitamin D levels in Indian systemic lupus erythematosus patients: association with disease activity index and interferon alpha. Arthritis Res Ther. 2014;16(1):R49.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"2976_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/0961203311422094","volume":"21","author":"CC Mok","year":"2012","unstructured":"Mok CC, Birmingham DJ, Ho LY, Hebert LA, Song H, Rovin BH. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Lupus. 2012;21(1):36\u201342.","journal-title":"Lupus."},{"issue":"10","key":"2976_CR8","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1177\/0961203311401457","volume":"20","author":"M Souto","year":"2011","unstructured":"Souto M, Coelho A, Guo C, Mendon\u00e7a L, Argolo S, Papi J, et al. Vitamin D insufficiency in Brazilian patients with SLE: prevalence, associated factors, and relationship with activity. Lupus. 2011;20(10):1019\u201326.","journal-title":"Lupus."},{"issue":"10","key":"2976_CR9","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.1093\/rheumatology\/keab090","volume":"60","author":"C Chew","year":"2021","unstructured":"Chew C, Reynolds JA, Lertratanakul A, Wu P, Urowitz M, Gladman DD, et al. Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort. Rheumatol Oxf Engl. 2021;60(10):4737\u201347.","journal-title":"Rheumatol Oxf Engl"},{"issue":"1","key":"2976_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/0961203309345775","volume":"19","author":"SMA Toloza","year":"2010","unstructured":"Toloza SMA, Cole DEC, Gladman DD, Iba\u00f1ez D, Urowitz MB. Vitamin D insufficiency in a large female SLE cohort. Lupus. 2010;19(1):13\u20139.","journal-title":"Lupus."},{"key":"2976_CR11","doi-asserted-by":"crossref","unstructured":"Jiang Z, Pu R, Li N, Chen C, Li J, Dai W, et al. High prevalence of vitamin D deficiency in Asia: A systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2021;1\u201310.","DOI":"10.1080\/10408398.2021.1990850"},{"issue":"5","key":"2976_CR12","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1093\/molbev\/msaa321","volume":"38","author":"A Bose","year":"2021","unstructured":"Bose A, Platt DE, Parida L, Drineas P, Paschou P. Integrating linguistics, social structure, and geography to model genetic diversity within India. Mol Biol Evol. 2021;38(5):1809\u201319.","journal-title":"Mol Biol Evol"},{"key":"2976_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-066452","volume":"376","author":"J Hahn","year":"2022","unstructured":"Hahn J, Cook NR, Alexander EK, Friedman S, Walter J, Bubes V, et al. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ. 2022;376:e066452.","journal-title":"BMJ."},{"key":"2976_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s41927-021-00223-1","volume":"5","author":"R Magro","year":"2021","unstructured":"Magro R, Saliba C, Camilleri L, Scerri C, Borg AA. Vitamin D supplementation in systemic lupus erythematosus: relationship to disease activity, fatigue and the interferon signature gene expression. BMC Rheumatol. 2021;5:53.","journal-title":"BMC Rheumatol"},{"issue":"8","key":"2976_CR15","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677\u201386.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2976_CR16","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00296-020-04766-3","volume":"41","author":"V Shobha","year":"2021","unstructured":"Shobha V, Aggarwal A, Rajasekhar L, Jain A, Gupta R, Das B, et al. Indian SLE Inception cohort for Research (INSPIRE): the design of a multi-institutional cohort. Rheumatol Int. 2021;41(5):887\u201394.","journal-title":"Rheumatol Int"},{"issue":"6","key":"2976_CR17","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.4103\/jfmpc.jfmpc_288_19","volume":"8","author":"RT Wani","year":"2019","unstructured":"Wani RT. Socioeconomic status scales-modified Kuppuswamy and Udai Pareekh\u2019s scale updated for 2019. J Fam Med Prim Care. 2019;8(6):1846\u20139.","journal-title":"J Fam Med Prim Care"},{"issue":"6","key":"2976_CR18","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35(6):630\u201340.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2976_CR19","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/art.1780390303","volume":"39","author":"D Gladman","year":"1996","unstructured":"Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996;39(3):363\u20139.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"2976_CR20","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/rheumatology\/key103","volume":"57","author":"Z Touma","year":"2018","unstructured":"Touma Z, Gladman DD, Su J, Anderson N, Urowitz MB. A novel lupus activity index accounting for glucocorticoids: SLEDAI-2K glucocorticoid index. Rheumatol Oxf Engl. 2018;57(8):1370\u20136.","journal-title":"Rheumatol Oxf Engl"},{"issue":"12 Pt 1","key":"2976_CR21","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00004","volume":"142","author":"JP Buyon","year":"2005","unstructured":"Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med. 2005;142(12 Pt 1):953\u201362.","journal-title":"Ann Intern Med"},{"issue":"7","key":"2976_CR22","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911\u201330.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2976_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102392","volume":"18","author":"MA Islam","year":"2019","unstructured":"Islam MA, Khandker SS, Alam SS, Kotyla P, Hassan R. Vitamin D status in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis. Autoimmun Rev. 2019;18(11):102392.","journal-title":"Autoimmun Rev"},{"issue":"37","key":"2976_CR24","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.2174\/1381612825666190111145848","volume":"24","author":"XR Wang","year":"2018","unstructured":"Wang XR, Xiao JP, Zhang JJ, Wu YG. Decreased serum\/plasma vitamin D levels in SLE patients: a meta-analysis. Curr Pharm Des. 2018;24(37):4466\u201373.","journal-title":"Curr Pharm Des"},{"issue":"5","key":"2976_CR25","doi-asserted-by":"publisher","first-page":"765","DOI":"10.4103\/ijem.IJEM_168_17","volume":"21","author":"S Selvarajan","year":"2017","unstructured":"Selvarajan S, Gunaseelan V, Anandabaskar N, Xavier AS, Srinivasamurthy S, Kamalanathan SK, et al. Systematic review on vitamin D level in apparently healthy Indian population and analysis of its associated factors. Indian J Endocrinol Metab. 2017;21(5):765\u201375.","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"2976_CR26","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1186\/s12889-021-11888-1","volume":"21","author":"MH Siddiqee","year":"2021","unstructured":"Siddiqee MH, Bhattacharjee B, Siddiqi UR, MeshbahurRahman M. High prevalence of vitamin D deficiency among the South Asian adults: a systematic review and meta-analysis. BMC Public Health. 2021;21(1):1823.","journal-title":"BMC Public Health"},{"issue":"3","key":"2976_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","volume":"21","author":"DD Bikle","year":"2014","unstructured":"Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21(3):319\u201329.","journal-title":"Chem Biol"},{"issue":"2","key":"2976_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1210\/jcem-67-2-373","volume":"67","author":"AR Webb","year":"1988","unstructured":"Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab. 1988;67(2):373\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2976_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ecl.2013.02.004","volume":"42","author":"JC Gallagher","year":"2013","unstructured":"Gallagher JC. Vitamin D and aging. Endocrinol Metab Clin N Am. 2013;42(2):319\u201332.","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"2","key":"2976_CR30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jocd.2011.12.007","volume":"15","author":"VK Shivane","year":"2012","unstructured":"Shivane VK, Sarathi V, Lila AR, Bandgar T, Joshi SR, Menon PS, et al. Peak bone mineral density and its determinants in an Asian Indian population. J Clin Densitom. 2012;15(2):152\u20138.","journal-title":"J Clin Densitom"},{"issue":"2","key":"2976_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/0976-7800.76215","volume":"1","author":"R Patni","year":"2010","unstructured":"Patni R. Normal BMD values for Indian females aged 20\u201380 years. J -Life Health. 2010;1(2):70\u20133.","journal-title":"J -Life Health"},{"issue":"4","key":"2976_CR32","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/rheumatology\/ker212","volume":"51","author":"CC Mok","year":"2012","unstructured":"Mok CC, Birmingham DJ, Leung HW, Hebert LA, Song H, Rovin BH. Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatol Oxf Engl. 2012;51(4):644\u201352.","journal-title":"Rheumatol Oxf Engl"},{"issue":"6","key":"2976_CR33","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3109\/03009742.2012.697189","volume":"41","author":"J Mu\u00f1oz-Ortego","year":"2012","unstructured":"Mu\u00f1oz-Ortego J, Torrente-Segarra V, Prieto-Alhambra D, Salman-Monte TC, Carbonell-Abello J. Prevalence and predictors of vitamin D deficiency in non-supplemented women with systemic lupus erythematosus in the Mediterranean region: a cohort study. Scand J Rheumatol. 2012;41(6):472\u20135.","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"2976_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1756-185X.2011.01698.x","volume":"15","author":"A Rizk","year":"2012","unstructured":"Rizk A, Gheita TA, Nassef S, Abdallah A. The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis. Int J Rheum Dis. 2012;15(3):261\u20137.","journal-title":"Int J Rheum Dis"},{"issue":"9","key":"2976_CR35","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1136\/ard.2005.046896","volume":"65","author":"GS Alarc\u00f3n","year":"2006","unstructured":"Alarc\u00f3n GS, Calvo-Al\u00e9n J, McGwin G, Uribe AG, Toloza SMA, Roseman JM, et al. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis. 2006;65(9):1168\u201374.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2976_CR36","doi-asserted-by":"publisher","first-page":"19713","DOI":"10.1038\/s41598-019-56297-y","volume":"9","author":"J Wei","year":"2019","unstructured":"Wei J, Zhu A, Ji JS. A comparison study of vitamin D deficiency among older adults in China and the United States. Sci Rep. 2019;9(1):19713.","journal-title":"Sci Rep"},{"issue":"12","key":"2976_CR37","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1002\/art.39803","volume":"68","author":"JA Reynolds","year":"2016","unstructured":"Reynolds JA, Rosenberg AZ, Smith CK, Sergeant JC, Rice GI, Briggs TA, et al. Brief Report: Vitamin D deficiency is associated with endothelial dysfunction and increases type I interferon gene expression in a murine model of systemic lupus erythematosus. Arthritis Rheumatol Hoboken NJ. 2016;68(12):2929\u201335.","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"2","key":"2976_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/0961203317716321","volume":"27","author":"SM Abdel Galil","year":"2018","unstructured":"Abdel Galil SM, El-Shafey AM, Abdul-Maksoud RS, El-Boshy M. Interferon alpha gene expression and serum level association with low vitamin D levels in Egyptian female patients with systemic lupus erythematosus. Lupus. 2018;27(2):199\u2013209.","journal-title":"Lupus."},{"issue":"3","key":"2976_CR39","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/0961203320973068","volume":"30","author":"AM Abo-Shanab","year":"2021","unstructured":"Abo-Shanab AM, Kholoussi S, Kandil R, Dorgham D. Cytokines, 25-OH vit D and disease activity in patients with juvenile-onset systemic lupus erythematosus. Lupus. 2021;30(3):459\u201364.","journal-title":"Lupus."},{"key":"2976_CR40","doi-asserted-by":"crossref","unstructured":"van den Hoogen LL, van Roon JAG, Mertens JS, et al. Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome. Annals of the Rheumatic Diseases. 2018;77:1810-4.","DOI":"10.1136\/annrheumdis-2018-213497"},{"issue":"1","key":"2976_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227069","volume":"15","author":"N Matsuoka","year":"2020","unstructured":"Matsuoka N, Fujita Y, Temmoku J, Furuya MY, Asano T, Sato S, et al. Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus. PLoS One. 2020;15(1):e0227069.","journal-title":"PLoS One"},{"issue":"4","key":"2976_CR42","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/09612033221082907","volume":"31","author":"P Mehta","year":"2022","unstructured":"Mehta P, Singh P, Aggarwal A. Serum and urinary galectin-9 and C-X-C motif chemokine ligand 10. Lupus. 2022;31(4):482\u20137.","journal-title":"Lupus."},{"issue":"11","key":"2976_CR43","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1177\/0961203315584811","volume":"24","author":"L Schneider","year":"2015","unstructured":"Schneider L, Colar da Silva AC, Werres Junior LC, Alegretti AP, Pereira dos Santos AS, Santos M, et al. Vitamin D levels and cytokine profiles in patients with systemic lupus erythematosus. Lupus. 2015;24(11):1191\u20137.","journal-title":"Lupus."},{"issue":"3","key":"2976_CR44","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00198-017-4316-5","volume":"29","author":"GL Lima","year":"2018","unstructured":"Lima GL, Paupitz JA, Aikawa NE, Alvarenga JC, Pereira RMR. A randomized double-blind placebo-controlled trial of vitamin D supplementation in juvenile-onset systemic lupus erythematosus: positive effect on trabecular microarchitecture using HR-pQCT. Osteoporos Int. 2018;29(3):587\u201394.","journal-title":"Osteoporos Int"},{"issue":"7","key":"2976_CR45","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1002\/art.39108","volume":"67","author":"C Aranow","year":"2015","unstructured":"Aranow C, Kamen DL, Dall\u2019Era M, Massarotti EM, Mackay MC, Koumpouras F, et al. Double-blind randomized placebo-controlled trial of the effect of vitamin D3 on the interferon signature in patients with systemic lupus erythematosus. Arthritis Rheumatol Hoboken NJ. 2015;67(7):1848\u201357.","journal-title":"Arthritis Rheumatol Hoboken NJ"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02976-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-022-02976-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02976-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T20:03:57Z","timestamp":1673035437000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-022-02976-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2976"],"URL":"https:\/\/doi.org\/10.1186\/s13075-022-02976-7","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,3]]},"assertion":[{"value":"9 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The respective institutional ethics committees (JIPMER and SGPGI) JIP\/IEC\/2018\/003 approved the study, and we conducted the study in accordance with the declaration of Helsinki\u2019s guidelines for human research. All patients gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the participants have provided written consent for the conduct of the study and anonymised publication of the information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}